Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that has been associated with aberrant microbiota. This review focuses on the recent molecular insights generated by analysing the intestinal microbiota in subjects suffering from IBS. Special emphasis is given to studies that compare and contrast the microbiota of healthy subjects with that of IBS patients classified into different subgroups based on their predominant bowel pattern as defined by the Rome criteria. The current data available from a limited number of patients do not reveal pronounced and reproducible IBS-related deviations of entire phylogenetic or functional microbial groups, but rather support the concept that IBS patients have alterations in the proportions of commensals with interrelated changes in the metabolic output and overall microbial ecology. The lack of apparent similarities in the taxonomy of microbiota in IBS patients may partially arise from the fact that the applied molecular methods, the nature and location of IBS subjects, and the statistical power of the studies have varied considerably. Most recent advances, especially the finding that several uncharacterized phylotypes show non-random segregation between healthy and IBS subjects, indicate the possibility of discovering bacteria specific for IBS. Moreover, tools are being developed for the functional analysis of the relationship between the intestinal microbiota and IBS. These approaches may be instrumental in the evaluation of the ecological dysbiosis hypothesis in the gut ecosystem. Finally, we discuss the future outlook for research avenues and candidate microbial biomarkers that may eventually be used in IBS diagnosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 6×
“Recent metagenomic sequence analysis of the GI tract microbiota has confirmed this and defined a reference set of over three million unique genes that vastly exceeds the coding capacity of the human genome (Qin et al., 2010).”
BackgroundInfluentialA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 2×
“Comparative microbiota analyses between multiple healthy subjects indicate that a limited proportion of phylotypes are shared between individuals, forming a common core microbiota that is assumed to be functionally redundant (Qin et al., 2010; Tap et al., 2009; Turnbaugh et al., 2009).”
BackgroundWoese, C. R. (1987) · Microbiological Reviews · doi:10.1128/mr.51.2.221-271.1987 · Cited by 5,042 · cited 1×
“As the evolutionary distance of different bacterial phyla is comparable with that of animals and plants in the rRNA-based tree of life (Woese, 1987), the vast genetic and phenotypic heterogeneity of the taxa classified into a phylum makes the phylum-wide differences unlikely.”
BackgroundLongstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 2×
“Interestingly, these taxa also stood out from clone libraries derived from IBD patients (Frank et al., 2007), and from an individual suffering from Clostridium difficile-associated disease (CDAD) with severe diarrhoea and colitis (Khoruts et al.”
BackgroundFunctional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Human gut microbiota in obesity and after gastric bypass
Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R., Rittmann, B. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812600106 · Cited by 1,880 · cited 1×
“Recently, the increase of Erysipelotrichi has been associated with obesity (Zhang et al., 2009) as well as high fat intake (Fleissner et al.”
BackgroundLow counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275 · cited 1×
“In the case of inflammatory bowel diseases (IBDs), such an approach has uncovered significant differences in overall diversity as well as in specific bacteria (Qin et al., 2010; Sokol et al., 2009).”
BackgroundAre dental diseases examples of ecological catastrophes?
Marsh, P. D. (2003) · Microbiology · doi:10.1099/mic.0.26082-0 · Cited by 1,256 · cited 1×
“This synopsis strongly suggests homeostasis of the microbiota to be a critical element in the pathophysiology of IBS, in a manner analogous to the development of dental caries according to the proposed ecological plaque hypothesis (Marsh, 2003).”
BackgroundPostinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Cited by
Items 101–200 of 263
Marteau, P., Guyonnet, D., Lafaye de Micheaux, P., & Gelu, S. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12078 · Cited by 50
Liu, Y., Yuan, X., Li, L., Lin, L., Zuo, X., Cong, Y., & Li, Y. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000146 · Cited by 54
Intestinal Microecology in Health and Wellness
Floch, M. H. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182309276 · Cited by 52
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission
Teruel, C., Garrido, E., & Mesonero, F. (2016) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v7.i1.78 · Cited by 48
(2014) · PubMed Central · Cited by 45
The gut microbiome and irritable bowel syndrome: State of art review
Salem, A., Singh, R., Ayoub, Y. K., Khairy, A. M., & Mullin, G. E. (2018) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2018.02.008 · Cited by 50
The Rationale and Clinical Effectiveness of Probiotics in Irritable Bowel Syndrome
Ringel, Y., & Ringel-Kulka, T. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822d32d3 · Cited by 44
“Evidence for the role of intestinal bacteria in the pathogenesis of irritable bowel syndrome (IBS) comes from epidemiological, physiological, and clinical data.(2,3) Epidemiological studies have identified gastrointestinal (GI) infection (eg, acute gastroenteritis) as a predictor for the development of IBS and that pa…”
Ramasamy, U. S., Venema, K., Schols, H. A., & Gruppen, H. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf501254z · Cited by 47
The contribution of alliaceous and cruciferous vegetables to dietary sulphur intake
Doleman, J. F., Grisar, K., Liedekerke, L. V., Saha, S., Roe, M. A., Tapp, H. S., & Mithen, R. F. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.04.098 · Cited by 46
Wang, Z., Xu, C., Liu, Y., Wang, X., Zhang, L., Li, M., Zhu, S., Xie, Z., Wang, P., Duan, L.-P., et al. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000192 · Cited by 50
Scanzi, J., Accarie, A., Muller, E., Pereira, B., Aissouni, Y., Goutte, M., Joubert‐Zakeyh, J., Picard, E., Boudieu, L., Mallet, C., et al. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12860 · Cited by 49
König, J., & Brummer, R. J. (2014) · Beneficial Microbes · doi:10.3920/bm2013.0033 · Cited by 42
“It is now widely accepted that a disbalanced gut ecosystem also plays an important role in the pathophysiology of IBS (Salonen et al. , 2010).”
Treatment of Dientamoeba fragilis in Patients with Irritable Bowel Syndrome
Engsbro, A. L., Stensvold, C. R., Nielsen, H. V., & Bytzer, P. M. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.11-0761 · Cited by 42
Revisión del papel de los probióticos en la patología gastrointestinal del adulto
Domingo, J. J. S. (2017) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2016.12.003 · Cited by 53
Yi, Q., Liu, J., Zhang, Y., Qiao, H., Chen, F., Zhang, S., & Guan, W. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.647242 · Cited by 45
Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome
Pike, B. L., Paden, K. A., Alcala, A. N., Jaep, K. M., Gormley, R. P., Maue, A. C., Christmann, B. S., Elson, C. O., Riddle, M. S., & Porter, C. K. (2015) · Journal of Travel Medicine · doi:10.1111/jtm.12218 · Cited by 46
Lappi, J., Aura, A., Katina, K., Nordlund, E., Kolehmainen, M., Mykkänen, H. M., & Poutanen, K. S. (2013) · Food & Function · doi:10.1039/c3fo60078e · Cited by 41
Naseri, K., Dabiri, H., Rostami‐Nejad, M., Yadegar, A., Houri, H., Olfatifar, M., Sadeghi, A., Saadati, S., Ciacci, C., Iovino, P., et al. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01868-5 · Cited by 52
Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function
Bayer, S. B., Gearry, R. B., & Drummond, L. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1327841 · Cited by 44
Mizock, B. A. (2015) · Disease-a-Month · doi:10.1016/j.disamonth.2015.03.011 · Cited by 61
The critical role of gut-brain axis microbiome in mental disorders
Basiji, K., Sendani, A. A., Ghavami, S. B., Farmani, M., Kazemifard, N., Sadeghi, A., Lotfali, E., & Aghdaei, H. A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01248-w · Cited by 58
“…Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus casei, Lactobacillus helveticus , Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus with gut microbiota, changed in IBS patients (Salonen et al. 2010 ; Jeffery et al. 2012b).”
BackgroundDo gut microbial communities differ in pediatric IBS and health?
Shankar, V., Agans, R., Holmes, B., Raymer, M., & Paliy, O. (2013) · Gut Microbes · doi:10.4161/gmic.24827 · Cited by 36
Engsbro, A. L., Stensvold, C. R., Nielsen, H. V., & Bytzer, P. M. (2013) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2013.861609 · Cited by 37
Zhang, J., Rodríguez, F., Navas, M. J., Costa-Hurtado, M., Almagro, V., Bosch-Camós, L., López, E., Cuadrado‐Matías, R., Accensi, F., Pina-Pedrero, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74651-3 · Cited by 44
Mechanisms of visceral pain in health and functional gastrointestinal disorders
Farmer, A. D., & Aziz, Q. (2014) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2014.01.002 · Cited by 43
“Several lines of evidence indicate that bacteia may be involved in the pathogenesis and pathophysiology of any FGIDs, via the metabolic capacity of luminal microbiota, and he potential of the mucosa associated microbiota to influence the ost via immune–microbial interactions [84].”
BackgroundJamshidi, P. K., Farsi, Y., Nariman, Z., Hatamnejad, M. R., Mohammadzadeh, B., Akbarialiabad, H., Nasiri, M. J., & Sechi, L. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914562 · Cited by 40
Hynönen, U., Rasinkangas, P., Satokari, R. M., Paulin, L. G., de Vos, W. M., Pietilä, T. E., Kant, R., & Palva, A. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.03.001 · Cited by 38
Self-citationOlteanu, G., Pană, M.-A., Busnatu, Ș., Lupuliasa, D., Neacșu, S. M., Mititelu, M., Musuc, A. M., Ioniță-Mîndrican, C.-B., & Boroghină, S. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105561 · Cited by 39
Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches
Camilleri, M., & Ford, A. C. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_102 · Cited by 41
Gut microbiome composition and risk factors in a large cross-sectional IBS cohort
Agnello, M., Carroll, L. N., Imam, N., Pino, R., Palmer, C., Varas, I., Greene, C. C., Hitschfeld, M., Gupta, S., Almonacid, D. E., et al. (2020) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000345 · Cited by 40
“2 14 19–21 Additional research is needed to investigate relationships between micro-organisms of the gut to help provide insights into disease state conditions and to support clinicians as they endeavour to treat IBS.”
Pakharukova, M. Y., Lishai, E. A., Zaparina, O. G., Baginskaya, N. V., Hong, S., Sripa, B., & Mordvinov, V. A. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011111 · Cited by 42
Molecular ecological tools to decipher the role of our microbial mass in obesity
Hermes, G. D. A., Zoetendal, E. G., & Smidt, H. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0016 · Cited by 37
Matrix metalloproteinase 9 contributes to gut microbe homeostasis in a model of infectious colitis
Rodrigues, D. M., Sousa, A. J., Hawley, S. P., Vong, L., Gareau, M. G., Kumar, S. A., Johnson‐Henry, K. C., & Sherman, P. M. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-105 · Cited by 35
“the haemolytic uremic syndrome [5], include intestinal dysbiosis which then contributes to the chronic symptoms that characterize post-infectious irritable bowel syndrome (IBS) [6] and chronic IBD [7].”
BackgroundThe trace aminergic system: a gender-sensitive therapeutic target for IBS?
Pretorius, L., & Smith, C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00688-1 · Cited by 32
“was associated with excess gas production, abdominal discomfort and bloating among IBS patients [204].”
BackgroundMethodological issues in the study of intestinal microbiota in irritable bowel syndrome.
Taverniti, V., & Guglielmetti, S. (2014) · PubMed · doi:10.3748/wjg.v20.i27.8821 · Cited by 40
Wang, T., Fu, J., Xiao, X., Lu, Z., Wang, F., Jin, M., Wang, Y., & Zong, X. (2021) · Mediators of Inflammation · doi:10.1155/2021/8032125 · Cited by 34
“Moreover, studies reported an increase in relative abundance of Firmicutes , mainly Clostridium cluster XIVa and Rumino-coccaceae , together with a reduction in the relative abundance of Bacteroidetes in the intestines of patients with IBS [22, 24 – 26].”
Postinfectious Functional Gastrointestinal Disorders
Mearin, F. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31821fbf58 · Cited by 31
CHIERICO, F. D., Gnani, D., Vernocchi, P., Petrucca, A., Alisi, A., Dallapiccola, B., Nobili, V., & Putignani, L. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15010684 · Cited by 36
“Recently, metagenomic studies of mucosal and fecal samples obtained from healthy subjects have shown the presence of Firmicutes, Bacteroidetes, Proteobacteria, Fusobacterium, Verrucomicrobia, Cyanobacteria, and Actinobacteria Spirochaetes in large populations [53–57].”
BackgroundLv, W., Liu, C., Li, Y., Chen, W., Li, Z.-Q., Li, Y., Xiong, Y., Chao, L., Xu, X., & Guo, S. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8194804 · Cited by 29
“For example, small intestinal bacterial overgrowth [13] and altered intestinal microbiota [14] are implicated in subgroups of patients with functional bowel disorders.”
BackgroundZong, S., Ye, H., Ye, Z., He, Y., Zhang, X., & Ye, M. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108656 · Cited by 31
Postinfectious Chronic Gut Dysfunction: From Bench to Bedside
Collins, S. M., Chang, C., & Mearin, F. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.2 · Cited by 28
Shankar, V., Reo, N. V., & Paliy, O. (2015) · Microbiome · doi:10.1186/s40168-015-0139-9 · Cited by 26
“Several of these causes are linked to the functionality of human intestinal microbiota [4], and a number of recent studies have provided emerging evidence of gut microbiota alterations in IBS [5–8].”
BackgroundClinical pilot study: efficacy of triple antibiotic therapy in
Nagel, R., Bielefeldt‐Ohmann, H., & Traub, R. J. (2014) · Gut Pathogens · doi:10.1186/s13099-014-0034-0 · Cited by 29
Lim, E.-S. (2017) · Applied Biological Chemistry · doi:10.1007/s13765-017-0333-5 · Cited by 30
“including multisystem organ failure, colon cancer, and irritable bowel syndrome [4].”
BackgroundGut Microbiota and Its Role in Anti-aging Phenomenon: Evidence-Based Review
Li, R., & Roy, R. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04423-y · Cited by 26
“The impact of the microbiome is on immuno-senescence [61–64].”
BackgroundJia, T., Zhao, S., Knott, K. K., Li, X., Liu, Y., Li, Y., Chen, Y., Yang, M., Lu, Y., Wu, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21117-2 · Cited by 25
Pensec, C., Gillaizeau, F., Guénot, D., Bessard, A., Carton, T., Leuillet, S., Campone, M., Neunlist, M., Blottière, H. M., & Vacon, F. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-65792-6 · Cited by 24
Bugs, Stool, and the Irritable Bowel Syndrome: Too Much Is as Bad as Too Little?
Talley, N. J., & Fodor, A. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.019 · Cited by 24
Bayrak, M. (2020) · Medicine · doi:10.1097/md.0000000000020577 · Cited by 27
“Several studies have consistently demonstrated that patients with IBS have altered gut microbiota.([23,24]) Thus, pathophysiologically, it is plausible to consider that in obese individuals, altered gut microbiota might lead to the development of both irritable bowels syndrome and metabolic syndrome.”
BackgroundShiftwork, functional bowel symptoms, and the microbiome
Rogers, A. E., Hu, Y., Yue, Y., Wissel, E. F., Petit, R. A., Jarrett, S. A., Christie, J. A., & Read, T. D. (2021) · PeerJ · doi:10.7717/peerj.11406 · Cited by 25
Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti-Inflammatory Agent
Quintero, J., Galvez-Ruiz, J. C., Ibarra, A. A. M., & Leyva‐Peralta, M. A. (2025) · Pharmaceuticals · doi:10.3390/ph18020193 · Cited by 23
“This suggests that these changes in the microbiota may affect the integrity of enterocytes in their cellular junctions, potentially leading to an inflammatory response [19,58–62].”
Duan, R., Chen, X., Wang, F., Zhang, T., & Ling, P. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.01.075 · Cited by 24
Does Day-to-Day Variability in Stool Consistency Link to the Fecal Microbiota Composition?
Vork, L., Penders, J., Jalanka, J., Bojić, S., van Kuijk, S. M. J., Salonen, A., de Vos, W. M., Rajilić-Stojanović, M. D., Weerts, Z. Z. R. M., Masclee, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.639667 · Cited by 18
Self-citationRodríguez, Ó., Hernández-Ruiz, J., López‐Vidal, Y., Charúa-Guindic, L., Bandeh-Moghaddam, H., Minzoni, A., Guzmán, C., & Schmulson, M. J. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12204 · Cited by 22
Qian, W., Li, W., Chen, X., Cui, L., Liu, X., Yao, J., Wang, X., Liu, Y., Li, C., Wang, Y., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154653 · Cited by 21
Fedorak, R. N., Vanner, S. J., Paterson, W. G., & Bridges, R. J. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/861478 · Cited by 18
“Furthermore, there has been considerable interest recently in the potential role of the host intestinal bacteria (microbiome) in the expression of IBS (7,8).”
BackgroundRifaximin for the treatment of irritable bowel syndrome
Cremonini, F., & Lembo, A. J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.651458 · Cited by 19
“Laboratory studies suggest different composition of the microbiome between patients with IBS and asymptomatic controls [2,3].”
BackgroundGut microbiota in gastrointestinal diseases
Bhattacharjee, G., Khambhati, K., Gohil, N., Singh, P., Gohil, J., Gautam, H., Maurya, R., Chu, D., Ramakrishna, S., & Singh, V. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.028 · Cited by 21
Roach, L. A., Meyer, B. J., Fitton, J. H., & Winberg, P. C. (2023) · Marine Drugs · doi:10.3390/md21070379 · Cited by 22
Vladimirovna, G. M., Dmitrievna, S. Y., Burakova, I. Y., Syromyatnikov, M., Chizhkov, P. A., Попов, Е. С., & Popov, V. N. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10111-4 · Cited by 19
“4 Alpha diversity index for the healthy patients before and after intake of lactic acid bacteria. p = 1.57 E − 07 on the health of the host; the decrease in their abundance has been connected to the development of irritable bowel syndrome [20, 21].”
InfluentialSpecial issue: The Human Intestinal Microbiota
Flint, H. J., O'Toole, P. W., & Walker, A. W. (2010) · Microbiology · doi:10.1099/mic.0.045443-0 · Cited by 17
“Four reviews in this special issue deal with the role of the human gut microbiota in irritable bowel syndrome (Salonen et al. , 2010), the metabolism of dietary phyto-chemicals (Kemperman et al. , 2010), interactions of probiotic bacteria with the gut mucosa (Sa´nchez et al. , 2010) and the impact…”
Mitchell, S. C. (2021) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2021.02.014 · Cited by 19
Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.
Deising, A. C., Gutiérrez, R. L., Porter, C. K., & Riddle, M. S. (2013) · Europe PMC (PubMed Central) · Cited by 16
A metaproteomic pipeline to identify newborn mouse gut phylotypes
CHIERICO, F. D., Petrucca, A., Mortera, S. L., Vernocchi, P., Rosado, M. M., Pieroni, L., Carsetti, R., Urbani, A., & Putignani, L. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.10.025 · Cited by 16
“In this context, a full comprehensive description of human gut phylotypes is essential to interpret gut homeostasis and perturbation [8–11].”
BackgroundTHERAPY OF THE POSTINFECTIOUS IRRITABLE BOWEL SYNDROME: AN UPDATE
Iacob, T., Țățulescu, D., & Dumitraşcu, D. L. (2007) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-752 · Cited by 18
“The differences in the intestinal microbiota between irritable bowel syndrome patients and healthy controls (HCs) have mostly been studied using fecal material, known as the most accessible source of the GI microbiota [11].”
BackgroundAlmansa, C., Agrawal, A. K., & Houghton, L. A. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.9 · Cited by 14
Huang, R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.800432 · Cited by 14
Rodríguez, Ó., Hernández-Ruiz, J., López‐Vidal, Y., Charúa-Guindic, L., Escobedo, G., & Schmulson, M. J. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16137 · Cited by 12
Free Radicals and Gastrointestinal Disorders
Brown, K., Molcan, E., Rajendiran, E., Nusrat, A., Baker, J., Ruscheinsky, S., & Gibson, D. L. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_137 · Cited by 15
Refractory inflammatory bowel disease—could it be an irritable bowel?
Meng, J., Agrawal, A., & Whorwell, P. J. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.173 · Cited by 12
Pathophysiologic Findings of Irritable Bowel Syndrome in China
Zhong, L., & Hou, X. (2012) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2012.18.1.19 · Cited by 10
“altered intestinal flora, which was found to correlate with GI symptoms, would play a role in the pathophysiology of IBS.(113) The therapeutic effect of probiotics varied in different studies for”
Yang, F., Chia, N., White, B. A., & Schook, L. B. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-136 · Cited by 21
“these results are preliminary [14-16] in nature, they all point to an area of rich research and the growing import-”
ResultWidjaja, F., & Rietjens, I. M. C. M. (2023) · Biomedicines · doi:10.3390/biomedicines11102658 · Cited by 13
Republished: Bacterial proteases in IBD and IBS
Steck, N., Mueller, K., Schemann, M., & Haller, D. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-300775rep · Cited by 15
Sometti, D., Ballan, C., Wang, H., Braun, C., & Enck, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-83994-4 · Cited by 11
Oliver, L., Ramió‐Pujol, S., Amoedo, J., Malagón, M., Serrano, M., Bahí, A., Lluansí, A., Torrealba, L., Busquets, D., Pardo, L., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.639948 · Cited by 11
Chronic Rhinosinusitis and Irritable Bowel Syndrome: A Case Report.
Kogan, M., Castillo, C. C., & Barber, M. S. (2016) · Europe PMC (PubMed Central) · Cited by 10
Portincasa, P., Celano, G., Serale, N., Vitellio, P., Calabrese, F. M., Chira, A., David, L., Dumitrascu, D. L., & Angelis, M. D. (2022) · Nutrients · doi:10.3390/nu14122488 · Cited by 11
“Microbial gut dysbiosis may be involved in the onset and maintenance of chronic conditions, such as FGIDs and food intolerances [19].”
BackgroundLluansí, A., Llirós, M., Carreras‐Torres, R., Bahí, A., Capdevila, M., Feliu, A., Vilà-Quintana, L., Masiques, N. E., Cueva, E., Peries, L., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297836 · Cited by 12
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00009-0 · Cited by 10
Patrick, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00051-2 · Cited by 9
The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome
Morales, P. S., Wijeyesekera, A., Robertson, M. D., Jackson, P. P. J., & Gibson, G. R. (2022) · Microorganisms · doi:10.3390/microorganisms10122338 · Cited by 11
Jandee, S., Chuensakul, S., & Maneerat, S. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00406-8 · Cited by 10
“Several past studies have demonstrated that patients with IBS have alterations in the gut microbiota [7].”
BackgroundLoose ends in the differential diagnosis of IBS-like symptoms
Lindberg, G., & Mohammadian, G. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1141035 · Cited by 8
Dysbiosis of the Intestinal Microbiota in IBS
Lyra, A., & Lahtine, S. (2012) · InTech eBooks · doi:10.5772/25759 · Cited by 9
“…GI tract of IBS subjects may have a functional role in the syndrome aetiology or merely reflect the status of the gut, but still have diagnostic or prognostic value in clinical practise and research (Kassinen, 2009; www.intechopen.com Current Concepts in Colonic Disorders 262 Salonen et al, 2010).”
Gregory, A., Gerhardt, K., Zhong, Z.-P., Bolduc, B., Temperton, B., Konstantinidis, K. T., & Sullivan, M. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.01.363960 · Cited by 8
Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The Imminent Study
Parsons, K., Goepp, J. G., DeChairo, B. M., Fowler, E., Markward, N., Hanaway, P. J., Mcbride, T., & Landis, D. L. (2014) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2013.100 · Cited by 7
Buret, A. G. (2016) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2016.11 · Cited by 7
Improving performance of broilers fed lower digestible protein diets
Qaisrani, S. N. (2014) · doi:10.18174/313161 · Cited by 9
Pendegraft, A. H., Guo, B., & Yi, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220961 · Cited by 9
The changes of respiratory microbiome between mild and severe asthma patients
Wang, Q., Guo, A., Sheng, M., & Zhou, H. (2021) · Microbiology and Immunology · doi:10.1111/1348-0421.12881 · Cited by 6
“For example, Streptococcus has the potential to regulate nutrient metabolism through producing massive ROS;(33,34) Veillonella can also cause blood glucose disorders in the human body.(35,36) In this study, we propose that the microbiome's products of amino acid and sugar metabolites may affect the immune system and a…”
BackgroundRamió‐Pujol, S., Amoedo, J., Serra‐Pagès, M., Torrealba, L., Bahí, A., Serrano, M., Malagón, M., Ibáñez‐Sanz, G., Gilabert, P., Marín, Í., et al. (2020) · GastroHep · doi:10.1002/ygh2.417 · Cited by 6
Prebiotics and Probiotics in Infant Nutrition
Zuppa, A. A., Alighieri, G., Scorrano, A., & Catenazzi, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00008-3 · Cited by 8
Oh, C. K., Park, J.-K., Kim, Y. J., & Kim, J. (2023) · Medicine · doi:10.1097/md.0000000000034899 · Cited by 4
Calenge, F., Martin, C., Floc'H, N. L., Phocas, F., Morgavi, D., Rogel-Gaillard, C., & Quéré, P. (2014) · INRAE Productions Animales · doi:10.20870/productions-animales.2014.27.3.3068 · Cited by 11
Higher enterococcus counts indicate a lower risk of colorectal adenomas: a prospective cohort study
Kawano, A., Ishikawa, H., Mutoh, M., Kubota, H., Matsuda, K., Tsuji, H., Matsumoto, K., Nomoto, K., Tanaka, R., Nakamura, T., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25130 · Cited by 6
Biotop Mensch. Wir sind besiedelt
Schumann, W. (2011) · Biologie in unserer Zeit · doi:10.1002/biuz.201110450 · Cited by 4
Diversity and sequence motifs of the bacterial SecA protein motor
del Val, C., & Bondar, A. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183319 · Cited by 4
Владимирович, И. К., Grechishnikova, V. R., Reshetova, M. S., & Ivashkin, V. T. (2021) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2021-31-1-54-63 · Cited by 4
“В ряде исследований при СРК вне зависимости от фенотипа демонстрируется увеличение числа представителей Firmicutes, главным образом за счет кластера Clostridium XIVa, и уменьшение представителей Bacteroides [61, 62].”
Development of an In Vitro Fermentation Model to Culture the Human Distal Gut Microbiota
McDonald, J. A. K. (2013) · The Atrium (University of Guelph) · Cited by 8
Metadata
- Authors
- Salonen, A., de Vos, W. M., & Palva, A.
- Affiliations
- University of Helsinki (FI)
- Laboratory of Microbiology, Wageningen University, Dreijenplein 10, 6703 HB Wageningen, The Netherlands
- ORCID
- Salonen, Anne
- Venue
- Microbiology
- Publisher
- Microbiology Society
- Published
- 2010-11-01
- Volume
- 156
- Issue
- 11
- Pages
- 3205-3215
- ISSN
- 1350-0872 (ISSN-L)
- 1465-2080
- OpenAlex
- W2118173539
- Cited by
- 264
- References
- 59
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 8 · 2021: 20 · 2020: 16 · 2019: 11 · 2018: 8 · 2017: 18 · 2016: 21 · 2015: 20 · 2014: 31 · 2013: 29 · 2012: 30
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Licence
- cc-by
- Locations
- Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Funders
- Tekes
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- irritable bowel syndrome, gut microbiota, dysbiosis, functional gastrointestinal disorders, Rome criteria, microbial biomarkers, IBS diagnosis, molecular microbiology
- MeSH terms
- Bacteria, DNA, Bacterial, Feces, Humans, Phylogeny, Biomarkers, Gastrointestinal Tract, Irritable Bowel Syndrome, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.